toggle visibility Search & Display Options

Select All    Deselect All
 |   | 
  Record Links
Author Rommen, K.; Schei, B.; Rydning, A.; H Sultan, A.; Morkved, S. url  doi
  Title Prevalence of anal incontinence among Norwegian women: a cross-sectional study Type Journal Article
  Year 2012 Publication BMJ Open Abbreviated Journal BMJ Open  
  Volume (down) 2 Issue 4 Pages  
  Abstract OBJECTIVE: Anal incontinence (AI) is a symptom associated with age, bowel symptoms and obstetric injuries. Primary aim of the study was to establish the prevalence of AI among women and secondarily to evaluate the impact on daily life and conditions associated with AI. DESIGN: A cross-sectional study. SETTING: Participants attended research stations located in different parts of Nord-Trondelag county, Norway. Data were collected through interviews, questionnaires and clinical examinations. PARTICIPANTS: In total, 40 955 community-dwelling women aged 30 years and older were invited. A total of 25 037 women participated, giving a participation rate of 61.1%. PRIMARY AND SECONDARY OUTCOME MEASURES: Fecal incontinence and flatal incontinence was defined as involuntary loss of feces and flatus weekly or more, respectively. AI was defined as the involuntary loss of feces and/or flatus weekly or more. Urgency was defined as the inability to defer defecation for 15 min. Statistical methods included prevalence estimates and logistic regression analysis. RESULTS: Questions about AI were completed by 20 391 (82.4%) women. Among the 20 391 women, AI was reported by 19.1% (95% CI 18.6% to 19.7%) and fecal incontinence was reported by 3.0% (95% CI 2.8% to 3.2%). Urgency was experienced by 2586 women (12.7%, 95% CI 12.2 to 13.1). Impact on daily life was stated by 794 (26.0%, 95% CI 24.4 to 27.5) women with AI. In bivariate age-adjusted analysis of AI, OR and CI for urgency (OR 3.19, 95% CI 2.92 to 3.49) and diarrhoea (OR 3.81, 95% CI 3.32 to 4.38) revealed strongest associations with AI. CONCLUSIONS: AI affects one in five women older than 30 years. Strongest associated symptoms are urgency and diarrhoea. TRIAL REGISTRATION NUMBER: The study was approved by the Regional Committee for Medical and Health Research Ethics (No. 2009/1214) and followed the Declaration of Helsinki.  
  Address Department of Public Health and General Practice, Norwegian University of Science and Technology, Trondheim, Norway  
  Corporate Author Thesis  
  Publisher Place of Publication Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 2044-6055 ISBN Medium  
  Area Expedition Conference  
  Notes PMID:22850167 Approved no  
  Call Number HUNT @ maria.stuifbergen @ Serial 1572  
Permanent link to this record
Select All    Deselect All
 |   | 

Save Citations:
Export Records: